Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
yo	O
lady	O
with	O
progressive	O
metastatic	O
urothelial	O
cancer	O
complicated	O
by	O
pulmonary	O
embolism	O
and	O
colovaginal	O
fistula	O
who	O
was	O
sent	O
from	O
___	O
clinic	O
with	O
lethargy	O
and	O
tachycardia	O
and	O
found	O
to	O
have	O
severe	O
hypercalcemia.	O
After	O
initial	O
management	O
of	O
her	O
hypercalcemia,	O
her	O
hospital	O
course	O
was	O
complicated	O
by	O
worsening	O
leukocytosis,	O
sinus	O
tachycardia,	O
anion	O
gap	O
metabolic	O
acidosis	O
(lactic	O
acidosis)	O
with	O
worsening	O
tachycardia,	O
hypotension,	O
and	O
pain.	O
On	O
___,	O
family	O
meeting	O
was	O
held	O
with	O
the	O
patient,	O
her	O
sister,	O
her	O
husband,	O
her	O
oncologist	O
Dr.	O
___,	O
___	O
care	O
NP	O
___,	O
and	O
primary	O
team.	O
The	O
patient	O
ultimately	O
decided	O
to	O
pursue	O
comfort	O
measures	O
and	O
DNR/DNI	O
status.	O
She	O
was	O
in	O
increased	O
pain	O
on	O
___,	O
so	O
started	O
a	O
morphine	O
drip.	O
Per	O
discussion	O
with	O
her	O
family	O
and	O
hospice	B-Lives_in_carehome
on	O
___,	O
they	O
decided	O
to	O
pursue	O
hospice	B-Lives_in_carehome
care,	O
so	O
she	O
was	O
discharged	O
from	O
acute	O
care	O
and	O
admitted	O
to	O
inpatient	O
hospice	B-Lives_in_carehome
at	O
___	O
at	O
that	O
time,	O
with	O
___	O
Hospice	B-Lives_in_carehome
following.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
___:	O
C1D1	O
gem/cis	O
(cisplatin	O
dose	O
reduced	O
25%	O
for	O
renal	O
function)	O
___:	O
C1D8	O
(gem)	O
(gemcitabine	O
reduced	O
25%	O
for	O
ANC	O
880)	O
___:	O
C2D1	O
gem/cis	O
(cisplatin	O
dose	O
reduced	O
15%	O
for	O
renal	O
function,	O
gemcitabine	O
dose	O
reduced	O
10%	O
for	O
recent	O
low	O
ANC)	O
___:	O
C2D8	O
(gem)	O
(gemcitabine	O
reduced	O
25%	O
for	O
ANC	O
1000)	O
___:	O
C3D1	O
gem/cis	O
(both	O
reduced	O
15%)	O
___:	O
CT	O
shows	O
incidental	O
PEs,	O
started	O
on	O
apixaban	O
___:	O
C4D1	O
gem/cis	O
___:	O
C4D8	O
gem	O
held	O
___:	O
Chemotherapy	O
held	O
for	O
fatigue	O
___:	O
C1	O
pembrolizumab	O
___:	O
C2	O
pembro	O
___:	O
C3	O
pembro	O
___:	O
C1	O
pemetrexed	O
___:	O
C2	O
pemetrexed	O
___:	O
C3	O
pemetrexed	O
PAST	O
MEDICAL	O
HISTORY:	O
Urothelial	O
carcinoma	O
(left	O
nephroureterectomy	O
___	O
-	O
Spinal	O
stenosis	O
-	O
Uterine	O
fibroids	O
status	O
post	O
total	O
hysterectomy	O
and	O
bilateral	O
salpingo-oophorectomy	O
___	O
___)	O
-	O
Depression	O
-	O
Prediabetes	O
-Pulmonary	O
embolism	O
Social	O
History:	O
___	O
Family	O
History:	O
Sister	O
had	O
breast	O
cancer	O
in	O
her	O
mid-___	O
Physical	O
Exam:	O
ON	O
ADMISSION	O
TO	O
HOSPICE:	B-Lives_in_carehome
GENERAL:	O
Alert	O
and	O
in	O
no	O
apparent	O
distress,	O
appeared	O
comfortable	O
laying	O
in	O
bed,	O
fatigued,	O
responds	O
verbally	O
to	O
questions,	O
soft	O
spoken	O
EYES:	O
Anicteric	O
RESP:	O
Breathing	O
is	O
non-labored	O
on	O
room	O
air.	O
GU:	O
No	O
GU	O
catheter	O
present	O
NEURO:	O
Alert,	O
conversant;	O
face	O
symmetric,	O
speech	O
fluent	O
but	O
slow	O
PSYCH:	O
Pleasant,	O
appropriate	O
affect,	O
calm,	O
cooperative	O
Patient	O
expired	O
on	O
___.	O
Pertinent	O
Results:	O
None.	O
No	O
labs	O
or	O
imaging	O
were	O
pursued	O
since	O
the	O
patient	O
was	O
on	O
hospice	B-Lives_in_carehome
care.	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
yo	O
lady	O
with	O
progressive	O
metastatic	O
urothelial	O
cancer	O
complicated	O
by	O
pulmonary	O
embolism	O
and	O
colovaginal	O
fistula	O
who	O
was	O
sent	O
from	O
___	O
clinic	O
with	O
lethargy	O
and	O
tachycardia	O
and	O
found	O
to	O
have	O
severe	O
hypercalcemia.	O
Due	O
to	O
worsening	O
metastatic	O
disease	O
with	O
complications,	O
she	O
opted	O
to	O
pursue	O
hospice	B-Lives_in_carehome
care	O
with	O
___.	O
She	O
was	O
treated	O
with	O
morphine	O
infusion	O
with	O
boluses	O
for	O
persistent	O
abdominal	O
pain	O
secondary	O
to	O
her	O
cancer,	O
as	O
well	O
as	O
PRN	O
medications	O
for	O
anxiety	O
and	O
secretions.	O
She	O
was	O
surrounded	O
by	O
a	O
very	O
large,	O
extended	O
family.	O
She	O
was	O
followed	O
by	O
___	O
care,	O
___,	O
and	O
her	O
primary	O
oncologist	O
Dr.	O
___	O
___	O
ultimately	O
expired	O
on	O
___.	O
Medications	O
on	O
Admission:	O
Morphine	O
infusion	O
Discharge	O
Medications:	O
Expired	O
Discharge	O
Disposition:	O
Expired	O
Discharge	O
Diagnosis:	O
Metastatic	O
urothelial	O
cancer	O
Discharge	O
Condition:	O
Expired	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
inpatient	O
hospice	B-Lives_in_carehome
care	O
for	O
ongoing	O
management	O
of	O
your	O
pain	O
and	O
other	O
symptoms.	O
You	O
were	O
followed	O
by	O
Seasons	O
Hospice	B-Lives_in_carehome
and	O
palliative	O
care.	O
It	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you	O
and	O
your	O
family.	O
Followup	O
Instructions:	O
___	O

